Click on each link for more information
Gradalis® Announces Initiation of Phase 3 Study of Vigil™ in Ewing’s sarcoma
Gradalis® implements L7 Informatics’ Enterprise Science Platform as part of initiating Phase 3 Study of Vigil™ in Ewing’s sarcoma
Gradalis® Presents Initial Data from Phase II U.S. Trial forEwing’s sarcoma at the Annual Meeting of the Children’s Oncology Group
